ABEMACICLIB
Clinical trials for ABEMACICLIB explained in plain language.
Never miss a new study
Get alerted when new ABEMACICLIB trials appear
Sign up with your email to follow new studies for ABEMACICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can blood tests predict severe diarrhea from breast cancer drug?
Knowledge-focused Not yet recruitingThis study will enroll 235 women with hormone receptor-positive, HER2-negative breast cancer who are taking abemaciclib after surgery. Researchers want to see if higher levels of the drug in the blood are linked to severe diarrhea, a common side effect. By understanding this link…
Matched conditions: ABEMACICLIB
Phase: PHASE4 • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Breast cancer study to track Real-World use of newer pills
Knowledge-focused Not yet recruitingThis study will follow 81 people with early-stage, hormone-positive breast cancer who are at high risk of the cancer coming back. Researchers want to see how often patients take their prescribed CDK4/6 inhibitor pills (abemaciclib or ribociclib) alongside standard hormone therapy…
Matched conditions: ABEMACICLIB
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC